Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
Varied trials throughout the small cell lung most cancers house have been delivered to mild following latest information, impacting how sufferers might be...
Tamron Little was identified with peritoneal mesothelioma in 2007 as a 21-year-old new mom. Atone for Tamron's blogs right here!There was a second early...
For sufferers with metastatic hormone receptor (HR)-positive, HER2-negative breast most cancers, there have been numerous trials to have come out of the 2025...
